- Home
- EMPD vs LFCR Comparison
EMPD vs LFCR Comparison
Compare EMPD & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EMPD | LFCR |
|---|---|---|
| Founded | 2020 | 1986 |
| Country | United States | United States |
| Employees | 15 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.8M | 143.9M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | EMPD | LFCR |
|---|---|---|
| Price | $5.34 | $4.60 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 289.6K | 189.6K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | $23.49 | N/A |
| Revenue Next Year | N/A | $5.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $3.19 | $3.63 |
| 52 Week High | $11.37 | $8.98 |
Technical Indicators
Market Signals| Indicator | EMPD | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 61.55 | 40.81 |
| Support Level | $4.56 | $3.63 |
| Resistance Level | $5.49 | $5.45 |
| Average True Range (ATR) | 0.24 | 0.27 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 88.33 | 20.50 |
Price Performance
Historical ComparisonAbout EMPD Empery Digital Inc.
Empery Digital Inc is an all-electric, off-road powersports vehicle company developing and building electric two and four-wheel motorcycles and utility terrain vehicles, also known as side-by-sides, along with a complete line of upgrades and accessories. The company's products include motorcycle and UTV products that are all-electric and designed for off-road use.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.